'김갑성' 기자의 전체기사
-
Top Thermal Camera Manufacturer Raytron Makes Breakthrou…
YANTAI, China, Aug. 28, 2025 -- As research in AI, advanced materials, renewable energy, and climate research accelerates, scientists require highly sensitive, precise, stable, and cost-effective tools to explore the invisible. Infrared thermal imaging has emerged as a vital "invisible microscope", enabling researchers to visualize heat flow, distribution, and transformation in real time. Raytron, with multi-spectral sensing R&D expertise, focuses on core infrared technologies and delivers full-spectrum SWIR, MWIR, and LWIR solutions for diverse applications. How Raytron'
- 김갑성 기자
- 2025-08-28 14:00
-
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SUR…
AUCKLAND, New Zealand, Aug. 27, 2025 -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospective, First-in-Human Clinical Evaluation of a Novel Tissue Apposition Device (ENIVO™) Following Simple Unilateral Mastectomy, which was published in the well-respected journal, Plastic and Reconstructive Surgery, Global Open. The ENIVO platform is designed for the management of 'dead space,' which is an open cavity created by surgical separation or excision of sof
- 김갑성 기자
- 2025-08-28 12:29
-
Titomic - Driving Innovation and Securing the Future in FY2025
HUNTSVILLE, Ala., Aug. 28, 2025 -- Titomic Limited (ASX: TTT), a global leader in advanced additive manufacturing and cold spray technology, is pleased to release its Annual Report for the full-year ended 30 June 2025. Highlights during FY2025: Strong Financial Growth: Revenue increased 37% year-on-year to AUD 8.1 million (FY2024: AUD 5.9 million). Successful Capital Raising: AUD 80 million raised. AUD 30 million October 2024 and AUD 50 million in July 2025 to fund U.S. expansion and global growth. Strategic plan on track: Strategic U.S
- 김갑성 기자
- 2025-08-28 11:52
-
CNA-Featured Mindset Coach Sharanya V Tackles Parentho…
With mental health now on Singapore's national agenda, efforts are underway to shift support into the community and reduce over-medicalisation. Recently featured by CNA Lifestyle, mindset coach and counsellor Sharanya V contributes to this conversation by addressing the everyday emotional pressures of parenthood, marriage and identity. SINGAPORE, Aug. 28, 2025 -- Sharanya V, a Singapore-based mindset coach and mental health counsellor, was recently featured by CNA Lifestyle as one of eight best podcasts for women in Singapore for her show The Parenting Revival Podcast. The recognition
- 김갑성 기자
- 2025-08-28 11:09
-
Chulalongkorn University Launches "ER-VIPE," a VR Innovation…
BANGKOK, Aug. 28, 2025 -- Because Every Minute in the ER Matters, the Chulalongkorn University Design for Society Center (CUD4S), in collaboration with the Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital of the Thai Red Cross Society, has launched the "ER-VIPE" (Emergency Room – Virtual Interprofessional Education), an innovative medical education tool. Using virtual simulation technology, ER-VIPE is designed to train interprofessional teams—doctors, nurses, pharmacists, radiologic technologist
- 김갑성 기자
- 2025-08-28 10:00
-
ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU…
SEOUL, South Korea, Aug. 28, 2025 -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced that it has entered into a strategic Memorandum of Understanding (MOU) with DAAN Biotherapeutics, a clinical-stage biotech focused on precision immuno-oncology therapeutics. Through this agreement, the two companies will establish a multi-faceted collaboration framework including stable supply of high-performance bioreagents, technical cooperation for immuno-oncology drug development, and joint resea
- 김갑성 기자
- 2025-08-28 09:54
-
Fujitsu develops AI agent platform for the healthcare sector…
TOKYO, Aug. 28, 2025 -- Fujitsu today announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provision in Japan's healthcare sector. The new platform includes an orchestrator AI agent, a centralized system that supports the collaboration and coordination of multiple specialized healthcare-specific agents developed by Fujitsu and other partner companies. The initiative aims to contribute to the rapid implementation of world-leading medical operational practices, thereby driving business transformation and imp
- 김갑성 기자
- 2025-08-28 08:40
-
AIM Vaccine Forecasts Surge in Stock Performance: Innovat…
HONG KONG, Aug. 28, 2025 -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today the release of its 2025 interim report, showcasing robust revenue growth. With major products entering the market phase, R&D costs are decreasing, and operational expenditures are being optimized. Four core innovative products are poised for commercialization, and significant advancements have been made in overseas market expansion. Two mRNA technology vaccines have simultaneously received clinical trial approvals in both the PRC and the U.S., leading to optimistic forecasts from instit
- 김갑성 기자
- 2025-08-28 07:45
-
Ascletis Announces Favorable and Differentiated Pharmaco…
- ASC30 oral once-daily tablet demonstrated approximately 2.3-fold to 3.3-fold greater drug exposure than orforglipron in a cross-trial comparison. - Higher drug exposure and favorable tolerability profile positions ASC30 oral once-daily tablet favorably compared to orforglipron. - Topline data from the Ascletis' U.S. Phase IIa study for ASC30 in participants with obesity or overweight are expected in the fourth quarter of 2025. HONG KONG, Aug. 28, 2025 -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces promising topline ph
- 김갑성 기자
- 2025-08-28 07:45
-
U. S. Air Force Global Strike Command Reinstates the M18 Pistol
Confirms the safety, reliability, and durability of the P320 based M18 NEWINGTON, N.H., Aug. 27, 2025 -- SIG SAUER applauds the USAF and the Global Strike Command in their diligence and expediency in the safety inspection related to the investigation into the tragic incident at F.E. Warren Air Force Base. We remain in direct contact with the Air Force Global Strike Command (AFGSC) leadership during this process and will continue to work with them as they return the M18 to service and provide Airmen with safe, reliable, and effective weapon systems. As affirmed by
- 김갑성 기자
- 2025-08-28 01:01
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025 23:42
- HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet 23:37
- United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits 22:00
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 20일 01시 20분